To further assess the utility of our method to study the downstream effect of genes involved in CLL or MCL pathogenesis, we targeted 2 important cell cycle regulatory proteins: cyclin D2 (CCND2) in CLL and cyclin D1 (CCND1) in MCL cells. This evidence concerns the gene CCND1 and B-cell chronic lymphocytic leukemia.